A pressure injury (PI) can cause pain and distress and increase treatment time for patients. In England, between 1,700 and 2,000 patients per month develop a PI, with an estimated associated cost to the National Health Service of more than £3.8 million per day.1 In the US, the annual cost of PI treatment is an estimated $26.8 billion, and the average cost of a PI (per hospital admission) is $43,000.2
Because PI incidence serves as a quality indicator for healthcare facilities,3 patients are screened on admission for PI risk. At-risk patients are then assessed by healthcare practitioners using visual and palpation tests.3 The patient’s PI risk is usually determined by the use of risk assessment tools/scales such as the Braden4 or Waterlow,5 although these are subjective measures.6–8 However, by the time the injury is visible, tissue damage has already taken place;9 perpendicular and shear forces contribute to tissue deformation and damage.10 The resulting breakdown of blood vessels and tissue cells causes an acute inflammatory reaction that increases both vasodilation and the permeability of blood vessels.11 Plasma leaks into the interstitial space creating localized edema, or subepidermal moisture (SEM).7,11
Given that tissue damage occurs before it is visible, the ability to determine the presence or absence of PI when it occurs would be useful. Oliveira et al12 undertook a systematic review of the literature pertaining to ultrasound, thermography, and SEM for predicting PI. The four SEM studies included indicated that SEM values increased with tissue damage and that the sacrum and the heels were the most common anatomical locations for the development of erythema and stage 1 PI. The authors concluded that SEM is a promising method for the detection and prediction of early tissue damage and PI, although further studies are required.
The SEM Scanner 200 (Bruin Biometrics LLC, Los Angeles, California) is a medical device that aids in the identification of pressure damage by measuring SEM. The device measures tissue dielectric properties from an electrode placed on the skin, which records changes in biocapacitance. These changes are related to changes in the volume of fluid in the skin and tissues under the area being assessed.13 Recorded scanner absolute values range from 0.3 to 3.9 units, where higher values indicate increased SEM and lower values, a deficit. In ordinary clinical use, repeated measurements are made at the site of suspected injury and contiguous locations to gauge the relative difference in SEM. The difference between the highest and lowest readings, the delta (Δ), is used to assess PI risk at measured anatomies. A Δ below 0.6 is indicative of low site-specific SEM variance, or healthy tissue. A Δ equal to or greater than 0.6 reflects increased site-specific SEM variance and is indicative of developing pressure damage.
Separate studies have demonstrated the effectiveness of the SEM biomarker and the SEM scanner in the detection of potential PI. An elevated SEM level has been found to indicate tissue damage 3 to 10 days before visual skin damage or PI formation7,14–17 and thus may serve as an early indicator.7,12,14–17 Smith18 evaluated the SEM 200 scanner for 2 months with patients deemed at risk of PI (Waterlow score over 10). The heels and sacrum were scanned once a day from admission; patients were deemed to have early pressure damage if the SEM Δ was 0.6 or higher. All 35 patients had a Δ 0.6 or higher, and all received preventive interventions. Although none went on to develop new PIs during their inpatient stay, one developed a PI within 7 days of discharge. The author concluded that the SEM scanner can inform clinicians about risk before the visual signs of deterioration occur and help direct care staff mitigate PI risk. Using the SEM scanner in a PI prevention pathway in a Canadian general hospital, Raizman et al19 demonstrated a reduction in hospital-acquired PI (HAPI) incidence by 90% compared with baseline. Littlefield and Kellett20 integrated Waterlow risk scores and SEM deltas in patient PI assessments at admission, during stays, and at discharge at two community hospitals in the UK. Results of their SEM-aided PI prevention and management protocol showed that stages 2 through 4 HAPIs were reduced by more than 95%; 75% of nurses described the scanner as easy to use, and 88% of nurses stated it provided additional information to support clinical decision-making. Finally, Okonkwo and colleagues’21 study involving 189 at-risk patients from 10 clinical study sites across the UK and US demonstrated that SEM measurements can accurately detect incipient pressure damage and that 87.5% of patients who developed PIs were previously detected by SEM. Importantly, SEM deltas identified early signs of pressure damage under the skin 5 days (median) earlier than visual skin assessment.21
To build on this previous research, this study’s primary objective was to collect SEM readings from healthy tissue (as determined by visual assessment and palpation tests by a qualified practitioner) both at and contiguous to the bony prominences of the sacrum and heel of patients without PIs. The study endpoint was to verify that healthy skin and tissue have a generally constant level of SEM (consistent absolute values and a Δ < 0.6) at the assessed anatomy, indicating the absence of localized inflammation. This is an important comparator for patients who are at risk of PIs or deep-tissue PIs, and where SEM deltas are elevated (Δ ≥ 0.6) but where the assessed skin and tissue are not exhibiting color, temperature, and/or edematous changes associated with PIs.
A total of 50 patients from a private physician’s office in Virginia Beach, Virginia, who were not at risk of PI development were enrolled in this study. Recruitment was performed by the principal investigator. Patients were older than 55 years, a population considered at risk of reduced mobility,22 a risk factor for PIs in adults.23 (The investigators also sought to compare results of this study to other, related studies involving patients with similar demographic profiles.) An equal number of males and females were enrolled. Exclusion criteria included broken skin at the anatomical locations being assessed, rheumatoid arthritis, gout, an autoimmune disorder, and use of corticosteroids.
The study conformed to the Federal Code of Regulations Part 81224 and ISO 14155.25 Ethics approval was obtained for the study (Quorum Review Inc, Seattle, Washington; QR#29154/1), and informed consent from each patient obtained. No follow-up procedures were required in the study, and no participants withdrew from the study. Consequently, no replacements of participants for analysis were made. A nominal stipend was provided to enrollees upon completion of study activities.
All assessments were performed during a single office visit lasting less than 2 hours. Consent, screening, and enrollment occurred on the same day as or immediately prior to the assessments. All data were recorded on case report forms (CRFs), and CRFs and datasets were audited by a site monitor. Minor findings by the site monitor were corrected in real time. A post hoc audit by a regulatory agency revealed no additional audit findings.
Demographic data (date of birth, sex, race and ethnicity, physical characteristics [height and weight], and medical history including comorbidities and medications considered potential confounders of SEM readings) were collected for each participant at the time of assessment. Prior to SEM scanner readings, a skin and tissue assessment consistent with those recommended in clinical guidelines23,26 was performed. The results and associated diagnosis (no PI) was recorded on the CRFs.
The SEM scanner readings were obtained by the principal investigator who had received previous training on the use of the device and was blinded to the interpretation of SEM values. Patients were placed in a supine position and then repositioned for subsequent readings. No wait/acclimation time was required before SEM readings were taken, and readings were taken in immediate succession.
Readings of absolute SEM values were collected from the center of and contiguous to the bony prominences of the heel and sacrum. Each reading captured in the CRFs for each box (Figures 1 and 2; sacrum and heels, respectively) was the average of three measurements. Readings for the sacrum were collected at the sacral spine S4 (Figure 1, box C), at 4 cm (Figure 1, boxes 5, 6, and 8) and 8 cm (Figure 1, boxes 9, 10, and 12) away from the center of the bony prominence in each of the proximal, right lateral, and left lateral directions. For the heel, readings were collected at the calcaneus (Figure 2, box C) and at 4 cm away from the center of the bony prominence in the plantar, medial, and lateral directions (Figure 2, boxes 9, 10, and 12). Readings over the Achilles tendon, being too far superior from the heel and lacking the fleshy tissue associated with PIs, were not obtained.
Following site monitoring, all data were locked and entered into SAS 9.4 (SAS Institute, Cary, North Carolina) for analysis. The data from the heel and sacrum were considered and computed separately. A repeated-measures analysis of variance, suitable for evaluating within-participant variability, was used to compare SEM absolute values from the anatomies assessed, as well as from the centers of the bony prominence at the sacrum and heel to readings taken within the surrounding areas at the specified distances from the center. The influence of potential confounding factors (body mass index, race, and sex) was explored using repeated-measures analysis of variance. All statistical comparisons were made at the two-sided 5% level of significance. The exploratory nature of this study did not require adjustments for multiplicity. No interim analyses or subgroup analyses were planned or conducted.
A total of 50 participants were enrolled. Table 1 summarizes the characteristics of study participants by sex.
To determine the distribution and variation of SEM measurements among participants, comparisons were made at each point within a single anatomic location. Absolute values for each anatomic location are shown in Tables 2 and 3, respectively. Absolute SEM mean and median measures at the sacrum varied by no more than 0.2 SEM units within each measurement location (2.5–2.3, all participants) and no more than 0.4 SEM units (2.6–2.2, male participants) between measurement locations.
Readings at and around the heel (Table 3) were generally lower than sacrum readings. The sites around the heel locations had more variability among readings, although the variance among mean (2.0–1.7, all participants) and median values (1.9–1.7, all participants) did not exceed 0.5 SEM units for either sex (2.0–1.5, male participants; 2.1–1.8, female participants). Readings on the medial side of the heel appeared lower than readings on the lateral side of the heel, although this difference was not statistically significant.
Figure 3 presents a box plot of the left (western) to right (eastern) readings at and around the sacrum; Figure 4 presents a box plot of the lateral to medial readings at the heel. Absolute values show a relatively “flat” spatial distribution of readings.
No adverse or serious adverse events were reported in the study.
A summary of the readings and sex comparison is outlined in Tables 2 and 3. Based on the Mann-Whitney-Wilcoxon P values, all measured anatomic locations were similar by sex except for the center of the bony prominence of the heel (U = 739.5, P = .0482, Table 3). Specifically, the reading taken at the calcaneus was lower in males than in females. However, no associations between sex and readings at the heel were observed.
Participant characteristics, medical history, and visual evaluation data were analyzed as potential confounders of SEM readings (Table 4). There were no statistically significant variations based on sex, age, race, ethnicity, body mass index, smoking status, diuretics, surgery, or osteoarthritis among participant measurements at the sacrum, and of those factors, only race indicated a variation between groups for heel measurements. However, calluses on the heel and race may be two potential confounders for heel readings (F test of the null hypothesis of no between-participant variability because of calluses, F = 15.87, P = .0002; F test of the null hypothesis of no between-subject variability because of race, F = 9.83, P = .003). These results demonstrate that the presence of calluses on the heel decreases SEM readings at the center as well as lateral and medial to the bony prominence, but not on the plantar surface.
The results in this study population also suggest that readings may be lower in the heel for African Americans than for whites. To further explore this result, average measurements around the heel were compared by F and P values. Except for the lateral site location, statistically significant differences were noted, although the number of African American participants was low (n = 9).
The consistency of SEM variation observed around each anatomic location in this study among healthy participants not at risk of PI suggests an absence of anatomy-specific inflammation and a relatively even spatial distribution of SEM.
The SEM scanner employed in this study uses the delta between the highest and lowest measurements around an anatomic site to assess the tissue status because absolute SEM measurements between individuals can differ substantially. In this study, readings at and around the sacrum were similar and had a generally even, unfluctuating pattern, whereas readings at and around the heel were relatively lower in value and showed more variability. This difference may be attributed to asymmetry in the vasculature of the medial and lateral aspects of the heel27 or to an as-yet unidentified confounder that might be common in persons older than 55 years.
Two potential confounders of readings were identified—calluses and race—both of which impacted heel but not sacral readings. Although the association between heel calluses and lower readings may have a biologic explanation given the thickened skin, the association between African American race and lower SEM readings is difficult to determine. It could be attributed to an as-yet unidentified confounder, such as undiagnosed peripheral vascular disease or diabetes.28,29 Of note, whereas the presence of a callus appears to lower all but the plantar SEM reading, African American race lowers all SEM readings almost equivalently and does not change the observed spatial pattern of relationships. However, both associations are based on a limited number of participants, and one or the other result may be attributable to chance alone. Other potential confounders did not significantly impact SEM readings.
As previously shown, studies using an SEM scanner have demonstrated early indications of PI.7,12,14–17 More recently, Lawrence and Hancock30 presented real-world evidence that explored the use of the SEM 200 Scanner as a component of a PI prevention program. In 11 centers in Canada, the UK, and Spain, more than 35,000 patient data values were obtained from 731 patients. Results demonstrated that 95% of patients showed an SEM delta over 0.5 during the usage period at some time point or anatomic location; 56% of facilities had no HAPI during the SEM usage period, and 73% of the facilities saw reductions in HAPI of more than 85% when SEM monitoring was implemented; and on average, across all 11 facilities, the HAPI was 1.2%, representing a 77% reduction over study start.
Implications for Practice
The SEM device is a handheld wireless device that is easy to use; it has high reported interoperator agreement and reliability.31 It can be used in any care setting and by any healthcare professional trained in its use, and it requires only a simple cleaning and disinfection between patients.32 Over time, the battery may require replacing, which is done by the manufacturer free of charge. All of this means the device is relatively simple and cost-effective to introduce into clinical practice.
In the UK, the cost per patient scanned using this device for an average episode of care (inpatient length of stay) is £1.54. The National Institute for Health and Care Excellence suggests that although this may represent a small additional cost compared with standard care, using the scanner to detect pressure damage earlier and implementing targeted interventions based on the results will ameliorate the cost of PI treatment.32
These data support the use of spatial (as opposed to single-point) readings using the SEM scanner at anatomic locations susceptible to PIs for the assessment of tissue status. These data further suggest that measures of SEM can be obtained from diverse populations for the assessment of skin and tissue status. The relatively “flat”/consistent spatial pattern of SEM absolute values found around the heels and sacra of healthy participants in this study supports the hypothesis that healthy tissue is not inflamed.
Additional research to gather SEM readings from patients diagnosed with PIs is needed to create a fuller clinical picture of SEM values for anatomies with confirmed PIs. Such comparison would help practitioners objectively assess which of their patients’ anatomies are at higher or lower risk of developing PIs, potentially resulting in targeted anatomy-specific treatment decisions.
1. National Health Service Improvement. Pressure ulcers: revised definition and measurement. Summary and recommendations. June 2018. https://improvement.nhs.uk/documents/2932/NSTPP_summary__recommendations_2.pdf
. Last accessed January 8, 2020.
2. Padula WV, Darlamente BA. The national cost of hospital-acquired pressure injuries in the United States. Int Wound J 2019 Jun;16(3):634–40.
3. National Institute for Health and Care Excellence. Pressure ulcers: prevention
and management of pressure ulcers [CG179]. 2018. www.nice.org.uk/guidance/cg179/uptake
. Last accessed January 20, 2020.
4. Bergstrom N, Braden BJ, Laguzza A, Holman V. The Braden Scale for predicting pressure sore risk. Nurs Res 1987;36:205–10.
5. Waterlow J. Pressure sores: a risk assessment card. Nurs Times 1985;81:49–55.
6. Lyder CH, Yu C, Emerling J, et al. The Braden Scale for pressure ulcer
risk: evaluating the predictive validity in black and Latino/Hispanic elders. Appl Nurs Res 1999;12(2):60–8.
7. Bates Jensen BM, McCreath HE, Pongquan V, Apeles NCR. Subepidermal moisture
differentiates erythema and stage I pressure ulcers in nursing home residents. Wound Repair Regen 2008;16(2):189–97.
8. Niezgoda JA, Mendez-Eastman S. The effective management of pressure ulcers. Adv Skin Wound Care 2006;19 Suppl 1:3–15.
9. Kottner J, Dassen T, Lahmann N. Comparison of two skin examination methods for grade 1 pressure ulcers. J Clin Nurs 2009;18(17):2464–9.
10. Young T. Back to basics: understanding the etiology of pressure ulcers. Wounds UK 2017;13(3):52–7.
11. Gefen A. The sub-epidermal moisture scanner: the principles of pressure injury prevention
using novel early detection technology. Wounds Int 2018;9(3).
12. Oliveira AL, Moore Z, Patton D, O’Connor T. Accuracy of ultrasound, thermography and subepidermal moisture
in predicting pressure ulcers: a systematic review. J Wound Care 2017;26(5):199–215.
13. Ross G, Gefen A. Assessment of sub-epidermal moisture by direct measurement of tissue biocapacitance. Med Eng Phys 2019;73:92–9.
14. Moore Z, Patten D, Rhodes SL, O’Connor T. Sub-epidermal moisture (SEM
) and bioimpedance: a literature review of a novel method for early detection of pressure-induced tissue damage (pressure ulcers). Int Wound J 2017;14(2):331–7.
15. Bates-Jensen BM, McCreath HE, Patlan A. Subepidermal moisture
detection of pressure induced tissue damage on the trunk: the pressure ulcer
detection study outcomes. Wound Repair Regen 2017;25(3):502–11.
16. Bates-Jensen BM, McCreath HE, Pongquan V. Subepidermal moisture
is associated with early pressure ulcer
damage in nursing home residents with dark skin tones: pilot findings. J Wound Ostomy Cont Nurs 2009;36(3):277–84.
17. O’Brien G, Moore Z. An investigation of the accuracy of early pressure ulcer
damage assessment using sub epidermal moisture measurement versus nurses’ visual skin assessment. Poster presented at the 2015 Wounds UK Conference, Harrogate UK.
18. Smith G. Improved patient safety with the use of the SEM
scanner (a pilot study). Poster presented at the 2016 Wounds UK Conference, Harrogate UK.
19. Raizman R, MacNeil M, Rappl L. Utility of a sensor-based technology to assist in the prevention
of pressure ulcers: a clinical comparison. Int Wound J 2018;15(6):1033–44.
20. Littlefield S, Kellett N. Chasing zero results from a new pressure ulcer prevention
bundle. Poster presented at the 2016 Wounds UK Conference, Harrogate UK.
21. Oknonkwo H, Bryant R, Milne J, et al. A blinded clinical study using subepidermal moisture
biocapacitance measurement device for early detection of pressure injuries. Wound Repair Regen 2020;1–11.
22. Ferrucci L, Cooper R, Shardell M, Simonsick EM, Schrack JA, Kuh D. Age-related change in mobility: perspectives from life course epidemiology and geroscience. J Gerontol A Biol Sci Med Sci 2016;71(9):1184–94.
23. National Pressure Injury
Advisory Panel. Prevention
and treatment of pressure ulcers/injuries: a clinical practice guideline. 2019. https://guidelinesales.com
. Last accessed January 20, 2020.
24. Food and Drug Administration. CFR—Code of Federal Regulations Title 21. Part 812 Investigational Device Exemptions. 2019. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=812&showFR=1&subpartNode=21:184.108.40.206.9.2
. Last accessed January 8, 2020.
25. International Organization for Standardization. ISO 14155:2011. Clinical investigation of medical devices for human subjects—good clinical practice. 2011. www.iso.org/standard/45557.html
. Last accessed January 20, 2020.
26. National Pressure Ulcer
Advisory Panel, European Pressure Ulcer
Advisory Panel, Pan Pacific Pressure Injury
and Treatment of Pressure Ulcers: Quick Reference Guide. Osborne Park, Australia: Cambridge Media, 2014.
27. Koulouris G, Morrison WB. Foot and ankle disorders: radiographic signs. Semin Roentgenol 2005;40(4):358–79.
28. Ghidei W, Collins TC. African Americans and peripheral arterial disease: a review article. ISRN Vasc Med 2012;2012:1–9.
29. Marshall MC. Diabetes in African Americans. Postgrad Med J 2005;81(962):734–40.
30. Lawrence R, Hancock K. Pressure Ulcer Prevention
Programme (PURP), Enabling Clinically Effective Management of Patients at Risk of Pressure Ulcers (PU). Accepted and presented at EWMA 2018, Krakow, Poland, 9-11 May, and accepted and presented at EPUAP 2018, Rome, Italy.
31. Clendenin M, Jaradeh K, Shamirian A, Rhodes SL. Inter-operator and inter-device agreement and reliability of the SEM
scanner. J Tissue Viability 2015;24(1):17–23.
32. National Institute for Health and Care Excellence. SEM
scanner for pressure ulcer prevention
. Medtech innovation briefing 182 [MIB182]. 2019. www.nice.org.uk/advice/mib182
. Last accessed January 20, 2020.